Tenaya Therapeutics (TNYA) Non Operating Income (2020 - 2026)
Tenaya Therapeutics (TNYA) recorded quarterly Non Operating Income of $793000.0 in Q1 2026, up 3072.0% quarter-over-quarter from $25000.0 in Q4 2025, and up 1933.33% on a YoY basis from $39000.0 in Q1 2025.
Tenaya Therapeutics (TNYA) Non Operating Income (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Non Operating Income history runs 7 years deep, the most recent figure standing at $793000.0 for Q1 2026.
- In Q1 2026, Non Operating Income rose 1933.33% year-over-year to $793000.0; the TTM figure through Mar 2026 stood at $1.5 million (up 30.74% YoY), while the FY2025 annual figure was $52000.0, down 36.59% from the prior year.
- Non Operating Income was $793000.0 for Q1 2026 at Tenaya Therapeutics, up from $25000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.0 million in Q1 2023 to a low of -$16000.0 in Q2 2025.
- Historically, Non Operating Income has averaged $501823.5 across 5 years, with a median of $98000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income jumped 107600.0% in 2024, then sank 1500.0% in 2025.
- A 5-year view of Non Operating Income shows it stood at -$3000.0 in 2022, then soared by 50466.67% to $1.5 million in 2023, then tumbled by 99.74% to $4000.0 in 2024, then surged by 525.0% to $25000.0 in 2025, then soared by 3072.0% to $793000.0 in 2026.
- The last three Non Operating Income figures came in at $793000.0 (Q1 2026), $25000.0 (Q4 2025), and $661000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Tenaya Therapeutics | 158.32 Mn | 158.32 Mn | - | 793,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 793,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 661,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 602,000.00 |
| Jun 30, 2022 | 222,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Sep 30, 2021 | 38,000.00 |
| Jun 30, 2021 | 27,000.00 |